SEOUL (Reuters) – South Korea’s drug safety ministry said on Thursday that Russia’s Sputnik V coronavirus vaccine and a shot developed by Novavax have been submitted for preliminary regulatory approval.
(Reporting by Hyonhee Shin; editing by John Stonestreet)
